Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to TILS Stock Lookup

(TILS) – Management Comments

Sep 10, 2019 07:05 AM Tiziana Life Sciences (TLSA) Announces Phase 1 Clinical Data Demonstrating Nasal Treatment with Foralumab was Well-Tolerated at All Doses

Back to TILS Stock Lookup